|
ZNF134 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.63400001599257E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.14340003710379E-09 |
| Normal-vs-Stage2 |
7.77610000000095E-05 |
| Normal-vs-Stage3 |
2.354400E-04 |
| Normal-vs-Stage4 |
7.80300046798743E-10 |
| Stage1-vs-Stage2 |
9.580400E-01 |
| Stage1-vs-Stage3 |
7.486000E-01 |
| Stage1-vs-Stage4 |
6.622800E-04 |
| Stage2-vs-Stage3 |
7.788600E-01 |
| Stage2-vs-Stage4 |
1.829640E-02 |
| Stage3-vs-Stage4 |
2.104300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.0183999976654E-08 |
| Normal-vs-AfricanAmerican |
9.80659999982869E-07 |
| Normal-vs-Asian |
3.006700E-04 |
| Caucasian-vs-AfricanAmerican |
9.614400E-01 |
| Caucasian-vs-Asian |
6.330400E-01 |
| AfricanAmerican-vs-Asian |
5.746600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.2801004700691E-10 |
| Normal-vs-Female |
1.541610E-02 |
| Male-vs-Female |
1.960740E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.0375999999489E-06 |
| Normal-vs-Extreme_Weight |
2.2415003186893E-10 |
| Normal-vs-Obese |
2.979100E-04 |
| Normal-vs-Extreme_Obese |
3.46689999997096E-06 |
| Normal_Weight-vs-Extreme_Weight |
4.085000E-01 |
| Normal_Weight-vs-Obese |
2.311400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.664400E-01 |
| Extreme_Weight-vs-Obese |
2.190400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.854200E-01 |
| Obese-vs-Extreme_Obese |
1.709610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.086410E-01 |
| Normal-vs-Age(41-60Yrs) |
1.9264999999713E-06 |
| Normal-vs-Age(61-80Yrs) |
8.7536999870963E-10 |
| Normal-vs-Age(81-100Yrs) |
2.55590000053374E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.735800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.689410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.086200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.478200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.150300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.347400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.87710003096697E-09 |
| Normal-VS-Type2 PRCC |
1.688700290714E-10 |
| Normal-VS-KIRP CIMP |
3.542400E-01 |
| Normal-VS-Unclassified PRCC |
3.528200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.444980E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.831400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.118780E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.192400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.358400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.011600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.86903875393818E-12 |
| Normal-vs-N1 |
1.057960E-02 |
| Normal-vs-N2 |
1.71864999999327E-05 |
| N0-vs-N1 |
9.474400E-02 |
| N0-vs-N2 |
2.866600E-01 |
| N1-vs-N2 |
1.818950E-01 |
|
|
